Prequalification of priority medicines

The Secretariat provided an overview of recent developments in the prequalification project. The Committee was informed that at a stakeholders meeting held on 26 September 2005, the project had been strongly endorsed by both the Director-General and by the stakeholders. The need for streamlining of procedures used in the context of the prequalification process, especially for drugs for malaria and tuberculosis, was recognized. The importance of promoting continued awareness of the prequalification project was emphasized. 

The Committee stressed the need for it to be kept informed of progress and developments in the prequalification project and encouraged stronger links between the prequalification project and normative work. 

---